Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling.

Gauri ShishodiaSweaty KoulHari K Koul

Published in: The Prostate (2019)

These data show for the first time that PCDH7 is overexpressed in a large number of patients with CRPC and suggest that PCDH7 may be an attractive target in subsets of patients with CRPC for whom there is no cure to-date.

Keyphrases

signaling pathway
electronic health record
cell proliferation
pi k akt
peripheral blood
big data
machine learning
artificial intelligence
deep learning